---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-002856"
form_type: "8-K"
ticker: "ZSQR"
cik: "0001759186"
company_name: "Z Squared Inc."
filed_at: "2025-04-28T23:59:59+00:00"
generated_at: "2026-05-23T05:07:42.406941+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Coeptis Therapeutics to merge with Dogecoin miner Z Squared; biopharma spun out

## Summary
- Coeptis to spin out biopharma; Z Squared becomes wholly-owned subsidiary focused on Dogecoin mining.
- Z Squared shareholders receive Coeptis equity for 9,000 DOGE mining machines; minimum asset value of $660.3M required.
- Post-close leadership: Z Squared CEO David Halabu becomes CEO; Michelle Burke COO; Dave Mehalick exits board.
- Closing expected Q3 2025; conditions include shareholder and regulatory approvals and Nasdaq listing.
- Combined company to rebrand as Z Squared, aiming to be largest U.S. publicly-traded Dogecoin miner.

## SEC filing metadata
- accession: 0001683168-25-002856
- form_type: 8-K
- ticker: ZSQR
- cik: 0001759186
- company_name: Z Squared Inc.
- filed_at: 2025-04-28T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.9
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1759186/000168316825002856/0001683168-25-002856-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1759186/000168316825002856/coeptis_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-002856
- JSON: https://secwatch.observer/filing/0001683168-25-002856.json
- Plain text: https://secwatch.observer/filing/0001683168-25-002856.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.